
Precipio, Inc. Share Price
PRPO$17.77
-$0.50 (-2.74%) Last updated on 19 Sep, 2025 | 00:51 ISTPrecipio, Inc. Stock Performance
Open $17.60 | Prev. Close $18.27 | Circuit Range N/A |
Day Range $17.56 - $17.60 | Year Range $3.90 - $21.50 | Volume 287 |
Average Traded $17.58 |
Precipio, Inc. Share Price Chart
$17.77
Please wait...
About Precipio, Inc.
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Precipio, Inc. Historical Data
Day | Open | Close | Change % |
---|---|---|---|
18-Sep-25 | $17.60 | $17.77 | -2.74% |
16-Sep-25 | $18.27 | $18.27 | -5.39% |
15-Sep-25 | $19.31 | $19.31 | -7.56% |
10-Sep-25 | $19.88 | $20.89 | -1.56% |
09-Sep-25 | $21.49 | $21.22 | +39.15% |
02-Sep-25 | $15.25 | $15.25 | -0.72% |
28-Aug-25 | $15.36 | $15.36 | -4.00% |
FAQs on Precipio, Inc. Share Price
Can I buy Precipio, Inc. shares in India?
Yes. You can buy Precipio, Inc. in India by opening an international trading account.
What is the share price of Precipio, Inc.?
As on 20 Sep '25, the share price of Precipio, Inc. PRPO is $17.77. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.
What is the 5 year returns of Precipio, Inc.?
The 5 year returns of Precipio, Inc. is -63.73% as on 20 Sep '25.
What are the high & low stock price of Precipio, Inc. today?
Precipio, Inc. stock price hit a high of $17.60 and low of $17.56 as on 20 Sep '25.
What is the 52-week high and low of Precipio, Inc. stock?
The 52-week high of Precipio, Inc. stock is $21.50, while the 52-week low is $3.90 as on 20 Sep '25.